Meyer T - Search Results

1

Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies.

Beaton L, Tregidgo HFJ, Znati SA, Forsyth S, Counsell N, Clarkson MJ, Bandula S, Chouhan M, Lowe HL, Thin MZ, Hague J, Sharma D, Pollok JM, Davidson BR, Raja J, Munneke G, Stuckey DJ, Bascal ZA, Wilde PE, Cooper S, Ryan S, Czuczman P, Boucher E, Hartley JA, Atkinson D, Lewis AL, Jansen M, Meyer T, Sharma RA. Beaton L, et al. Among authors: meyer t. J Vasc Interv Radiol. 2022 Sep;33(9):1034-1044.e29. doi: 10.1016/j.jvir.2022.04.033. Epub 2022 May 5. J Vasc Interv Radiol. 2022. PMID: 35526675

2

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Tibballs J, Meyer T, Patch DW, Burroughs AK. Marelli L, et al. Among authors: meyer t. Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):6-25. doi: 10.1007/s00270-006-0062-3. Cardiovasc Intervent Radiol. 2007. PMID: 17103105 Review.

3

Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization.

Ayaru L, Pereira SP, Alisa A, Pathan AA, Williams R, Davidson B, Burroughs AK, Meyer T, Behboudi S. Ayaru L, et al. Among authors: meyer t. J Immunol. 2007 Feb 1;178(3):1914-22. doi: 10.4049/jimmunol.178.3.1914. J Immunol. 2007. PMID: 17237442

4

Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy.

Maniaci V, Davidson BR, Rolles K, Dhillon AP, Hackshaw A, Begent RH, Meyer T. Maniaci V, et al. Among authors: meyer t. Eur J Surg Oncol. 2009 Jun;35(6):617-21. doi: 10.1016/j.ejso.2008.12.009. Epub 2009 Jan 13. Eur J Surg Oncol. 2009. PMID: 19144491

5

Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors.

Hochhauser D, Meyer T, Spanswick VJ, Wu J, Clingen PH, Loadman P, Cobb M, Gumbrell L, Begent RH, Hartley JA, Jodrell D. Hochhauser D, et al. Among authors: meyer t. Clin Cancer Res. 2009 Mar 15;15(6):2140-7. doi: 10.1158/1078-0432.CCR-08-1315. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276288 Clinical Trial.

6

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization.

Gillmore R, Stuart S, Kirkwood A, Hameeduddin A, Woodward N, Burroughs AK, Meyer T. Gillmore R, et al. Among authors: meyer t. J Hepatol. 2011 Dec;55(6):1309-16. doi: 10.1016/j.jhep.2011.03.007. Epub 2011 Apr 15. J Hepatol. 2011. PMID: 21703196

7

Circulating tumor cells as prognostic markers in neuroendocrine tumors.

Khan MS, Kirkwood A, Tsigani T, Garcia-Hernandez J, Hartley JA, Caplin ME, Meyer T. Khan MS, et al. Among authors: meyer t. J Clin Oncol. 2013 Jan 20;31(3):365-72. doi: 10.1200/JCO.2012.44.2905. Epub 2012 Dec 17. J Clin Oncol. 2013. PMID: 23248251

8

γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000).

Wu J, Clingen PH, Spanswick VJ, Mellinas-Gomez M, Meyer T, Puzanov I, Jodrell D, Hochhauser D, Hartley JA. Wu J, et al. Among authors: meyer t. Clin Cancer Res. 2013 Feb 1;19(3):721-30. doi: 10.1158/1078-0432.CCR-12-2529. Epub 2012 Dec 18. Clin Cancer Res. 2013. PMID: 23251007 Free PMC article.

9

Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms.

Khan MS, Kirkwood AA, Tsigani T, Lowe H, Goldstein R, Hartley JA, Caplin ME, Meyer T. Khan MS, et al. Among authors: meyer t. Clin Cancer Res. 2016 Jan 1;22(1):79-85. doi: 10.1158/1078-0432.CCR-15-1008. Epub 2015 Jul 21. Clin Cancer Res. 2016. PMID: 26199388

10

Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.

Lemech CR, Ensell L, Paterson JC, Eminowicz G, Lowe H, Arora R, Arkenau HT, Widschwendter M, MacDonald N, Olaitan A, Mould T, Meyer T, Hartley J, Mitra A, Ledermann JA, McCormack M, Kristeleit RS. Lemech CR, et al. Among authors: meyer t. Oncology. 2016;91(1):48-54. doi: 10.1159/000445999. Epub 2016 Jun 3. Oncology. 2016. PMID: 27256106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,803 results

Search Page

Filters